Chronic myeloid leukaemia (CML) is characterised in virtually all cases by the presence of a translocation between chromosomes 9 and 22 resulting in the formation of the Philadelphia chromosome and a BCR-ABL1 fusion protein [1–4]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.